Immunotherapy for Recurrent Cervical Cancer Refractory to Platinum-based Chemotherapy

Clinical trial NCT04188860 · COMPLETED

Trial details

NCT number: NCT04188860
Sponsor: Lei Li
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent Cervical Carcinoma Persistent Advanced Cervical Carcinoma Chemotherapy Anti-PD-1 Antibody Immunotherapy

Start date: 2019-12-06
Primary completion: 2022-01-06
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.